Medication Management for Anxiety, Insomnia, and Attention Issues

First-Line Recommendation

Bupropion is the most appropriate medication choice for a patient with a history of ADHD, anxiety, insomnia, and concerns about weight gain, as it promotes weight loss and has demonstrated effectiveness for both ADHD symptoms and depression 1, 2
The American College of Obstetricians and Gynecologists recommends bupropion as a first-line treatment for depression in patients with a history of ADHD, due to its effectiveness in promoting weight loss and improving ADHD symptoms 3, 2
The recommended starting dose of bupropion is 100-150 mg daily, which can be titrated to maintenance doses of 100-150 mg twice daily, with a maximum recommended dose of 450 mg per day 2

The patient's previous positive response to bupropion suggests it would be effective again, though side effect management would need to be addressed, according to the American Journal of Obstetrics and Gynecology 2
Tricyclic antidepressants like amitriptyline are associated with significant weight gain, which is a specific concern for this patient, as noted in Diabetes Care 1, 4

Common side effects of bupropion include headache, insomnia, and anxiety, which should be monitored closely, as recommended by Praxis Medical Insights 2
For insomnia, consider low-dose trazodone or non-pharmacological interventions like sleep hygiene education and cognitive behavioral therapy, as suggested by Nature Reviews Disease Primers 1, 5
If anxiety worsens, consider adjunctive treatments like buspirone augmentation or mindfulness-based stress reduction techniques, as recommended by the American Journal of Obstetrics and Gynecology 3, 5

Regular assessment for emergence of psychotic symptoms is essential, especially during medication adjustments, as noted in the British Journal of Psychiatry 6
The patient's history of ADHD may require additional targeted treatment if concentration issues persist despite bupropion, according to Praxis Medical Insights 2

Lurasidone or aripiprazole could be considered as alternative options if bupropion is not tolerated, as they are more weight-neutral atypical antipsychotics, as noted in Gastroenterology 1
Viloxazine, a newer non-stimulant option for ADHD, has shown efficacy in adults and could be considered, as recommended by the American Journal of Obstetrics and Gynecology 3

Assess response to medication after 4 weeks, with particular attention to changes in anxiety, mood, and concentration, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 7, 2
Regular monitoring for emergence of suicidal ideation is essential, particularly during the initial treatment phase, as noted in the Journal of the American Academy of Child and Adolescent Psychiatry 7